Ticker
PAR
Analysis
Paradigm Biopharmaceuticals Ltd. (PAR) Stock Analysis
Paradigm Biopharmaceuticals Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PAR.
Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PAR.
Stock profile
Asset type
Stock
Market cap
$74.0M
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Currency
AUD
Ticker listings
Paradigm Biopharmaceuticals Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- PAR primary listing
- A12FJ4
- PBIGF
- P86
Latest Paradigm Biopharmaceuticals Ltd. news
PAR Completes Enrolment in Pivotal Phase 3
PAR Completes Enrolment in Pivotal Phase 3
Results of Share Purchase Plan
Results of Share Purchase Plan
DSMB 20% Review Supports Phase 3, Moldova Activated
DSMB 20% Review Supports Phase 3, Moldova Activated
March 2026 Quarterly Activities Report & Appendix 4C
March 2026 Quarterly Activities Report & Appendix 4C
Upsized $14M Placement Extends Runway Post IA
Upsized $14M Placement Extends Runway Post IA
Research sections
Valuation
Review valuation context for Paradigm Biopharmaceuticals Ltd..
Future growth
Review future growth context for Paradigm Biopharmaceuticals Ltd..
Past performance
Review past performance context for Paradigm Biopharmaceuticals Ltd..
Financial health
Review financial health context for Paradigm Biopharmaceuticals Ltd..
Dividend
Review dividend context for Paradigm Biopharmaceuticals Ltd..
Management
Review management context for Paradigm Biopharmaceuticals Ltd..
Ownership
Review ownership context for Paradigm Biopharmaceuticals Ltd..
Other information
Review other information context for Paradigm Biopharmaceuticals Ltd..
Community
Review community context for Paradigm Biopharmaceuticals Ltd..